Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
20 June 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Companies
Top Ten Companies //
Browse A - Z of companies
Merck KGaA
(Merck)
Merck
(Merck KGaA)
Pfizer
Roche
Novartis
GlaxoSmithKline
(GSK)
GSK
(GlaxoSmithKline)
Bristol-Myers Squibb
Lilly
Bayer
Browse the A - Z of Companies
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
L
Lab Clausen
Lab Teuto Brasileiro
LabCorp
Labopharm
Laboratoire francais du Fractionnement et des Biotechnologies
Laboratoires Majorelle
Laboratoires SERB
Laboratoires SMB
Laboratoires Thea
Laboratorios Cinfa
Laboratorios Gautier
Laboratorios Phoenix
Laboratorios SALVAT
Labormed Pharmaceuticals
LadaTech
Lanthio Pharma
Laser SA
Lectus Therapeutics
Lee's Pharmaceutical
Lentigen
LEO Pharma
Leo Pharmaceutical Products
Leoni Studer
Lexicon Pharmaceuticals
LFB Biotechnologies
Life Sciences Entrepreneurs
Life Technologies
Ligand Pharmaceuticals
LigoCyte
LigoCyte Pharmaceuticals
Lilly
Limerick Bioscience
Link Medicines
Lipoxen
Liquidia Technologies
Litha Healthcare
LoneStar Heart
Lonza
Lotus Tissue Repair
Lpath
LTS
Luitpold Pharma
Luminex
Lundbeck
Lundbeckfond
Lupin
Lux Biosciences
Lux Research
Luye Pharma
Lycera Corp
Hot Topics
Most Read
Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
It's official: "obesity is a disease," says AMA
Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
It's official: "obesity is a disease," says AMA
Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD